Induced Pluripotent Stem Cell Market
Induced Pluripotent Stem Cell Market Study by Hepatocytes, Fibroblasts, Keratinocytes, Neurons, and Others for Drug Development, Regenerative Medicine, and Toxicity Testing from 2024 to 2034
Analysis of Induced Pluripotent Stem Cell Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Induced Pluripotent Stem Cell Market Outlook (2024 to 2034)
The global induced pluripotent stem cell market size is estimated to be US$ 2,013.3 million in 2024. The market is projected to register a CAGR of 7.1% and reach a valuation of US$ 3,980.8 million by 2034.
The market is predicted to rise owing to the increasing capital investments for the automation of iPSC production, rapid therapy product pipeline, and understanding of the functionality of omics-based data. Additionally, surging technological advancements are expected to propel market growth.
Tissue engineering and biotechnology firms are also investing in research and development to expand the scope of application of iPSCs and develop new stem cell therapies to treat various diseases, which is expected to drive market demand.
Key Drivers Propelling the Induced Pluripotent Stem Cell Market
- Increasing investments in research and development activities to advance the healthcare sector.
- Expanding the scope of application in induced pluripotent stem cells (iPSCs) in precision medicine.
- Surging government spending and rising knowledge about stem cell research in several organizations are pushing forth market growth.
- Rising incidences of chronic diseases and consequent spike in the usage of stem cells in medical treatments.
- Growing number of genomics projects, rising research funding, and surging deployment of genome engineering in personalized medicine are contributing to market expansion.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 2,013.3 million |
| Forecasted Market Value (2034F) | US$ 3,980.8 million |
| Projected Growth Rate (2024 to 2034) | 7.1%CAGR |
| Neurons Segment Growth Rate (2024 to 2034) | 6% CAGR |
| Regenerative Medicine Segment Growth Rate (2024 to 2034) | 6.6% CAGR |
| North America Market Share (2024) | 48.7% |
| East Asia Market Share (2024) | 17.2% |
| Key Companies Profiled in the Induced Pluripotent Stem Cell Industry Report | Sumitomo Dainippon Pharma Co. Ltd.; Ncardia; REPROCELL USA Inc.; Thermo Fisher Scientific Inc.; FUJIFILM Cellular Dynamics Inc.; Fate Therapeutics Inc.; Evotec SE; Pluricell Biotech; Cynata Therapeutics Limited; Takara Bio Inc.; ViaCyte Inc.; Axol Bioscience Ltd.; Others |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Trend Augments the Induced Pluripotent Stem Cell Market Growth?
“Increasing Research-based Studies for iPSCs to Widen its Application Scope”
Surging iPSCs-based research studies are favoring the market’s progress. Presently, more than a hundred clinical trials are underway that deploy iPSCs for the development of iPSC products or disease intervention techniques.
Moreover, the increasing knowledge about the benefits associated with induced pluripotent stem cells like the flexibility of ethical implications related to embryonic stem cells and removal of animal models are creating a conducive ground for business entities to deploy iPSCs in multiple applications. Some of the applications are toxicological tests, modeling diseases, new drugs, etc.
What are the Challenges Limiting the Induced Pluripotent Stem Cell Market?
“Restrictions in Therapeutic Applications of iPSC”
The primary obstacle that tampers with the therapeutic applications of iPSC includes the reprogramming method that uses retroviruses to complete. Retroviruses increase safety concerns, in addition to permanent integration of transgene and modification of copy number into the iPSC’s genome. Thus, reducing iPSC’s efficacy.
“Significant Expenses Related to Stem Cell Research and Therapies”
Expenditure related to stem cell research is significant. Stem cell research also takes a longer duration to develop and use induced pluripotent stem cells. These factors are restricting the uptake of iPSC. Additionally, ethical issues related to stem cell research and therapies are also constraining the market demand for iPSCs.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Region-wise Insights
Which Region Holds a Greater Share of the Induced Pluripotent Stem Cell Market?
“North America Boasts a Larger Share in the iPSC Market”
| Attribute | Details |
|---|---|
| CAGR (2024 to 2034) | 6% |
The North America market is predicted to acquire a significant share of 48.7% in 2024. The regional market is estimated to obtain US$ 980 million in 2024 and is projected to expand at 6% over the forecast period. By 2034, the market size is expected to settle at US$ 1,762 million.
North America is observing an upsurge in multiple diseases, resulting in heightened demand for novel treatments. Due to this, many healthcare companies are creating unique treatments like regenerative and personalized medicine.
Market players in the region are thus finding significant opportunities as stem cell research gains significant use in the development of regenerative and personalized medicine.
How is the East Asia Market Performing on the Global Platform?
“Growing Awareness about the Potential of Personalized Treatments in East Asia”
| Attribute | Details |
|---|---|
| CAGR (2024 to 2034) | 9.4% |
The East Asia induced pluripotent stem cell market is anticipated to possess a value share of 17.2% in 2024. This region is estimated to attain US$ 347 million in 2024. By 2034, the regional market is projected to reach US$ 854 million, registering a CAGR of 9.4% through 2034. The market in East Asia is driven by rising economies, growing awareness about the potential of personalized treatments, and low-cost stem cell-based research.
Country-wise Insights
Which Country Leads the North America Market?
“The United States Acquires a Larger Share of the Regional Market”
| Attribute | Details |
|---|---|
| CAGR (2024 to 2034) | 5.7% |
The United States induced pluripotent stem cell industry is expected to obtain a share of 91.8% in 2024. The market is estimated to accumulate US$ 899 million in 2024. By 2034, the market is expected to be valued at US$ 1,568 million, recording a CAGR of 5.7%.
The market growth is propelled by the increasing incidence of chronic diseases and enhanced healthcare infrastructure in the country. Additionally, private and government initiatives also have a strong impact on the market’s growth. Key players are employing strategic business models for the market’s growth.
Which Country is Emerging as a Lucrative Market in East Asia?
“Rapidly Rising Demand for Induced Pluripotent Stem Cells in Japan”
| Attribute | Details |
|---|---|
| CAGR (2024 to 2034) | 10% |
The market in Japan is projected to record a CAGR of 10% through 2034. The market is estimated to extrapolate from US$ 134 million in 2024 to US$ 348 million by 2034. Based on value share, the market is estimated to occupy 38.6% share in 2024.
The market in Japan is anticipated to be driven by a high number of research universities and start-ups. The market is also catalyzed by collaborative efforts by international firms. New service or product launches in this country are also expected to propel market growth. Further, improving healthcare plans in Japan are also attracting investors and stakeholders.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Segment-wise Insights
Which Cell Type is Dominating the Market?
“Neurons Lead the Induced Pluripotent Stem Cell Market”
| Attribute | Details |
|---|---|
| Market Share in 2024 | 30.9% |
Neurons occupy a 30.9% market share in 2024. The segment is estimated to attain US$ 622.6 million in 2024. The segment is projected to register a 6% CAGR through 2034 and reach a value of US$ 1,115.6 million. The segment is driven by the rising research and development activities in the induced pluripotent stem cell market.
Which Application of iPSC Contributes to Market Growth?
“iPSC Finds Substantial Use in Regenerative Medicine”
| Attribute | Details |
|---|---|
| Market Share in 2024 | 47.3% |
Regenerative medicine obtains a 47.3% share in 2024. The segment is estimated to be valued at US$ 951.5 million in 2024, and rise at a CAGR of 6.6% through 2034. By 2034, the demand for iPSCs for regenerative medicine is expected to be worth US$ 1,799.4 million. The segment is driven by the expansion of applications and vigorous product pipelines by leading firms. In regenerative therapy, iPSCs can be seen proceeding with clinical trials. Thus, augmenting the segment’s growth.
Which End User Widely Employs iPSCs?
“Biotechnology Companies Capture a Massive Share of the Market”
| Attribute | Details |
|---|---|
| Market Share in 2024 | 57.1% |
Biotechnology companies occupy a 57.1% share in 2024. The segment is estimated to obtain US$ 1,149.0 million in 2024. Recording a CAGR of 6.6%, the segment is forecast to capture a value of US$ 2,179.4 million by 2034. The segment is driven by the presence and adoption of multiple kits, instruments, and consumables in addition to iPSC products.
Pharmaceutical and biotechnology companies are focusing on product launches via research and development efforts, creating market opportunities.
Competitive Landscape in the Induced Pluripotent Stem Cell Market
Key players in the induced pluripotent stem cell market include Sumitomo Dainippon Pharma Co. Ltd., Ncardia, REPROCELL USA Inc., Thermo Fisher Scientific Inc., FUJIFILM Cellular Dynamics Inc., Fate Therapeutics Inc., Evotec SE, Pluricell Biotech, Cynata Therapeutics Limited, Takara Bio Inc., ViaCyte Inc., Axol Bioscience Ltd., and Others.
Suppliers of induced pluripotent stem cells are raising their investments in research and development activities to enhance their portfolio for stem cell therapies, which is gaining traction for the treatment of many chronic diseases. Leading businesses are collaborating with other players to increase their customer base. Additionally, they are making strategic moves like partnership and acquisition to uplift their visibility and drive up the market competition.
Latest Developments in the Induced Pluripotent Stem Cell Market
- In August 2021, Fate Therapeutics officially announced that FT819 had been successful in treating its first patient in a clinical trial. FT819, which is a CAR-T cell treatment, was developed utilizing iPSCs.
- Bristol Myers Squibb and Century Therapeutics entered into a strategic partnership agreement in January 2022. Under this agreement, both companies are expected to work together to develop allogeneic cell treatments extracted from iPSCs to treat severe myeloid leukemia and many myelomas.
- In May 2022, Sernova and Evotec bonded over a strategic alliance to develop an iPSC-based beta replacement therapy for type 1 and 2 diabetes.
- In July 2021, SCM Lifescience Co. Ltd., which is a South Korea-based cell therapy developing firm, announced that it had in-license a diabetes drug from Allele Biotechnology and Pharmaceuticals, Inc. This drug is a pancreatic beta cell therapy extracted from iPSCs, and the deal has been signed at a valuation of US$ 0.75 million.
Segmentation of Induced Pluripotent Stem Cell Market Research
-
By Cell Type:
- Hepatocytes
- Fibroblasts
- Keratinocytes
- Neurons
- Others
-
By Application Type:
- Drug Development
- Regenerative Medicine
- Toxicity Testing
-
By End User:
- Academic and Research Institutes
- Biotechnology Companies
-
By Region:
- North America
- Europe
- Latin America
- East Asia
- South Asia and Oceania
- Middle East and Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Process
- 5.1. Manual iPSC Production Process
- 5.2. Automated iPSC Production Process
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Workflow
- 6.1. Reprogramming
- 6.2. Cell Culture
- 6.3. Cell Characterization / Analysis
- 6.4. Engineering
- 6.5. Others
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
- 7.1. Instruments/ Devices
- 7.2. Automated Platforms
- 7.3. Consumables & Kits
- 7.3.1. Media
- 7.3.2. Kits
- 7.3.3. Others
- 7.4. Services
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
- 8.1. Drug Development & Discovery
- 8.2. Regenerative Medicine
- 8.3. Toxicology Studies
- 8.4. Others
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-use
- 9.1. Research & Academic Institutes
- 9.2. Biotechnology & Pharmaceutical Companies
- 9.3. Hospitals & Clinics
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. South Asia and Pacific
- 10.6. East Asia
- 10.7. Middle East and Africa
- 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 18. Key Countries Market Analysis
- 19. Market Structure Analysis
- 20. Competition Analysis
- 20.1. Lonza
- 20.2. Axol Bioscience Ltd.
- 20.3. Evotec
- 20.4. Hitachi, Ltd.
- 20.5. ViaCyte, Inc.
- 20.6. Merck KGaA
- 20.7. REPROCELLS, Inc.
- 20.8. Fate Therapeutics
- 20.9. Thermo Fisher Scientific, Inc.
- 20.10. FUJIFILM Cellular Dynamics, Inc.
- 20.11. Applied StemCells, Inc.
- 21. Assumptions & Acronyms Used
- 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Process, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Workflow, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 5: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 6: Global Market Value (US$ Million) Forecast by End-use, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by Process, 2019 to 2034
Table 9: North America Market Value (US$ Million) Forecast by Workflow, 2019 to 2034
Table 10: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 11: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 12: North America Market Value (US$ Million) Forecast by End-use, 2019 to 2034
Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Latin America Market Value (US$ Million) Forecast by Process, 2019 to 2034
Table 15: Latin America Market Value (US$ Million) Forecast by Workflow, 2019 to 2034
Table 16: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 17: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 18: Latin America Market Value (US$ Million) Forecast by End-use, 2019 to 2034
Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 20: Western Europe Market Value (US$ Million) Forecast by Process, 2019 to 2034
Table 21: Western Europe Market Value (US$ Million) Forecast by Workflow, 2019 to 2034
Table 22: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 23: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 24: Western Europe Market Value (US$ Million) Forecast by End-use, 2019 to 2034
Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: Eastern Europe Market Value (US$ Million) Forecast by Process, 2019 to 2034
Table 27: Eastern Europe Market Value (US$ Million) Forecast by Workflow, 2019 to 2034
Table 28: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 29: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 30: Eastern Europe Market Value (US$ Million) Forecast by End-use, 2019 to 2034
Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 32: South Asia and Pacific Market Value (US$ Million) Forecast by Process, 2019 to 2034
Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Workflow, 2019 to 2034
Table 34: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 36: South Asia and Pacific Market Value (US$ Million) Forecast by End-use, 2019 to 2034
Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 38: East Asia Market Value (US$ Million) Forecast by Process, 2019 to 2034
Table 39: East Asia Market Value (US$ Million) Forecast by Workflow, 2019 to 2034
Table 40: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 41: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 42: East Asia Market Value (US$ Million) Forecast by End-use, 2019 to 2034
Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 44: Middle East and Africa Market Value (US$ Million) Forecast by Process, 2019 to 2034
Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Workflow, 2019 to 2034
Table 46: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 47: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034
Table 48: Middle East and Africa Market Value (US$ Million) Forecast by End-use, 2019 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Million) by Process, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Workflow, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Product, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Application, 2024 to 2034
Figure 5: Global Market Value (US$ Million) by End-use, 2024 to 2034
Figure 6: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 7: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 10: Global Market Value (US$ Million) Analysis by Process, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Process, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Process, 2024 to 2034
Figure 13: Global Market Value (US$ Million) Analysis by Workflow, 2019 to 2034
Figure 14: Global Market Value Share (%) and BPS Analysis by Workflow, 2024 to 2034
Figure 15: Global Market Y-o-Y Growth (%) Projections by Workflow, 2024 to 2034
Figure 16: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 17: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 18: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 19: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 20: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 21: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 22: Global Market Value (US$ Million) Analysis by End-use, 2019 to 2034
Figure 23: Global Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 24: Global Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 25: Global Market Attractiveness by Process, 2024 to 2034
Figure 26: Global Market Attractiveness by Workflow, 2024 to 2034
Figure 27: Global Market Attractiveness by Product, 2024 to 2034
Figure 28: Global Market Attractiveness by Application, 2024 to 2034
Figure 29: Global Market Attractiveness by End-use, 2024 to 2034
Figure 30: Global Market Attractiveness by Region, 2024 to 2034
Figure 31: North America Market Value (US$ Million) by Process, 2024 to 2034
Figure 32: North America Market Value (US$ Million) by Workflow, 2024 to 2034
Figure 33: North America Market Value (US$ Million) by Product, 2024 to 2034
Figure 34: North America Market Value (US$ Million) by Application, 2024 to 2034
Figure 35: North America Market Value (US$ Million) by End-use, 2024 to 2034
Figure 36: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 37: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 40: North America Market Value (US$ Million) Analysis by Process, 2019 to 2034
Figure 41: North America Market Value Share (%) and BPS Analysis by Process, 2024 to 2034
Figure 42: North America Market Y-o-Y Growth (%) Projections by Process, 2024 to 2034
Figure 43: North America Market Value (US$ Million) Analysis by Workflow, 2019 to 2034
Figure 44: North America Market Value Share (%) and BPS Analysis by Workflow, 2024 to 2034
Figure 45: North America Market Y-o-Y Growth (%) Projections by Workflow, 2024 to 2034
Figure 46: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 47: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 48: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 49: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 50: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 51: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 52: North America Market Value (US$ Million) Analysis by End-use, 2019 to 2034
Figure 53: North America Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 54: North America Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 55: North America Market Attractiveness by Process, 2024 to 2034
Figure 56: North America Market Attractiveness by Workflow, 2024 to 2034
Figure 57: North America Market Attractiveness by Product, 2024 to 2034
Figure 58: North America Market Attractiveness by Application, 2024 to 2034
Figure 59: North America Market Attractiveness by End-use, 2024 to 2034
Figure 60: North America Market Attractiveness by Country, 2024 to 2034
Figure 61: Latin America Market Value (US$ Million) by Process, 2024 to 2034
Figure 62: Latin America Market Value (US$ Million) by Workflow, 2024 to 2034
Figure 63: Latin America Market Value (US$ Million) by Product, 2024 to 2034
Figure 64: Latin America Market Value (US$ Million) by Application, 2024 to 2034
Figure 65: Latin America Market Value (US$ Million) by End-use, 2024 to 2034
Figure 66: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 67: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 70: Latin America Market Value (US$ Million) Analysis by Process, 2019 to 2034
Figure 71: Latin America Market Value Share (%) and BPS Analysis by Process, 2024 to 2034
Figure 72: Latin America Market Y-o-Y Growth (%) Projections by Process, 2024 to 2034
Figure 73: Latin America Market Value (US$ Million) Analysis by Workflow, 2019 to 2034
Figure 74: Latin America Market Value Share (%) and BPS Analysis by Workflow, 2024 to 2034
Figure 75: Latin America Market Y-o-Y Growth (%) Projections by Workflow, 2024 to 2034
Figure 76: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 77: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 78: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 79: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 80: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 82: Latin America Market Value (US$ Million) Analysis by End-use, 2019 to 2034
Figure 83: Latin America Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 84: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 85: Latin America Market Attractiveness by Process, 2024 to 2034
Figure 86: Latin America Market Attractiveness by Workflow, 2024 to 2034
Figure 87: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 88: Latin America Market Attractiveness by Application, 2024 to 2034
Figure 89: Latin America Market Attractiveness by End-use, 2024 to 2034
Figure 90: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 91: Western Europe Market Value (US$ Million) by Process, 2024 to 2034
Figure 92: Western Europe Market Value (US$ Million) by Workflow, 2024 to 2034
Figure 93: Western Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 94: Western Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 95: Western Europe Market Value (US$ Million) by End-use, 2024 to 2034
Figure 96: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 97: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 100: Western Europe Market Value (US$ Million) Analysis by Process, 2019 to 2034
Figure 101: Western Europe Market Value Share (%) and BPS Analysis by Process, 2024 to 2034
Figure 102: Western Europe Market Y-o-Y Growth (%) Projections by Process, 2024 to 2034
Figure 103: Western Europe Market Value (US$ Million) Analysis by Workflow, 2019 to 2034
Figure 104: Western Europe Market Value Share (%) and BPS Analysis by Workflow, 2024 to 2034
Figure 105: Western Europe Market Y-o-Y Growth (%) Projections by Workflow, 2024 to 2034
Figure 106: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 107: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 108: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 109: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 110: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 112: Western Europe Market Value (US$ Million) Analysis by End-use, 2019 to 2034
Figure 113: Western Europe Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 114: Western Europe Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 115: Western Europe Market Attractiveness by Process, 2024 to 2034
Figure 116: Western Europe Market Attractiveness by Workflow, 2024 to 2034
Figure 117: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 118: Western Europe Market Attractiveness by Application, 2024 to 2034
Figure 119: Western Europe Market Attractiveness by End-use, 2024 to 2034
Figure 120: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: Eastern Europe Market Value (US$ Million) by Process, 2024 to 2034
Figure 122: Eastern Europe Market Value (US$ Million) by Workflow, 2024 to 2034
Figure 123: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 124: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034
Figure 125: Eastern Europe Market Value (US$ Million) by End-use, 2024 to 2034
Figure 126: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 127: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Process, 2019 to 2034
Figure 131: Eastern Europe Market Value Share (%) and BPS Analysis by Process, 2024 to 2034
Figure 132: Eastern Europe Market Y-o-Y Growth (%) Projections by Process, 2024 to 2034
Figure 133: Eastern Europe Market Value (US$ Million) Analysis by Workflow, 2019 to 2034
Figure 134: Eastern Europe Market Value Share (%) and BPS Analysis by Workflow, 2024 to 2034
Figure 135: Eastern Europe Market Y-o-Y Growth (%) Projections by Workflow, 2024 to 2034
Figure 136: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 137: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 138: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 139: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 142: Eastern Europe Market Value (US$ Million) Analysis by End-use, 2019 to 2034
Figure 143: Eastern Europe Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 144: Eastern Europe Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 145: Eastern Europe Market Attractiveness by Process, 2024 to 2034
Figure 146: Eastern Europe Market Attractiveness by Workflow, 2024 to 2034
Figure 147: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 148: Eastern Europe Market Attractiveness by Application, 2024 to 2034
Figure 149: Eastern Europe Market Attractiveness by End-use, 2024 to 2034
Figure 150: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 151: South Asia and Pacific Market Value (US$ Million) by Process, 2024 to 2034
Figure 152: South Asia and Pacific Market Value (US$ Million) by Workflow, 2024 to 2034
Figure 153: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034
Figure 154: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034
Figure 155: South Asia and Pacific Market Value (US$ Million) by End-use, 2024 to 2034
Figure 156: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 157: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Process, 2019 to 2034
Figure 161: South Asia and Pacific Market Value Share (%) and BPS Analysis by Process, 2024 to 2034
Figure 162: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Process, 2024 to 2034
Figure 163: South Asia and Pacific Market Value (US$ Million) Analysis by Workflow, 2019 to 2034
Figure 164: South Asia and Pacific Market Value Share (%) and BPS Analysis by Workflow, 2024 to 2034
Figure 165: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Workflow, 2024 to 2034
Figure 166: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 167: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 168: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 169: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by End-use, 2019 to 2034
Figure 173: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 174: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 175: South Asia and Pacific Market Attractiveness by Process, 2024 to 2034
Figure 176: South Asia and Pacific Market Attractiveness by Workflow, 2024 to 2034
Figure 177: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 178: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034
Figure 179: South Asia and Pacific Market Attractiveness by End-use, 2024 to 2034
Figure 180: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 181: East Asia Market Value (US$ Million) by Process, 2024 to 2034
Figure 182: East Asia Market Value (US$ Million) by Workflow, 2024 to 2034
Figure 183: East Asia Market Value (US$ Million) by Product, 2024 to 2034
Figure 184: East Asia Market Value (US$ Million) by Application, 2024 to 2034
Figure 185: East Asia Market Value (US$ Million) by End-use, 2024 to 2034
Figure 186: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 187: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 190: East Asia Market Value (US$ Million) Analysis by Process, 2019 to 2034
Figure 191: East Asia Market Value Share (%) and BPS Analysis by Process, 2024 to 2034
Figure 192: East Asia Market Y-o-Y Growth (%) Projections by Process, 2024 to 2034
Figure 193: East Asia Market Value (US$ Million) Analysis by Workflow, 2019 to 2034
Figure 194: East Asia Market Value Share (%) and BPS Analysis by Workflow, 2024 to 2034
Figure 195: East Asia Market Y-o-Y Growth (%) Projections by Workflow, 2024 to 2034
Figure 196: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 197: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 198: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 199: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 200: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 201: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 202: East Asia Market Value (US$ Million) Analysis by End-use, 2019 to 2034
Figure 203: East Asia Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 204: East Asia Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 205: East Asia Market Attractiveness by Process, 2024 to 2034
Figure 206: East Asia Market Attractiveness by Workflow, 2024 to 2034
Figure 207: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 208: East Asia Market Attractiveness by Application, 2024 to 2034
Figure 209: East Asia Market Attractiveness by End-use, 2024 to 2034
Figure 210: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 211: Middle East and Africa Market Value (US$ Million) by Process, 2024 to 2034
Figure 212: Middle East and Africa Market Value (US$ Million) by Workflow, 2024 to 2034
Figure 213: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034
Figure 214: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034
Figure 215: Middle East and Africa Market Value (US$ Million) by End-use, 2024 to 2034
Figure 216: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 217: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Process, 2019 to 2034
Figure 221: Middle East and Africa Market Value Share (%) and BPS Analysis by Process, 2024 to 2034
Figure 222: Middle East and Africa Market Y-o-Y Growth (%) Projections by Process, 2024 to 2034
Figure 223: Middle East and Africa Market Value (US$ Million) Analysis by Workflow, 2019 to 2034
Figure 224: Middle East and Africa Market Value Share (%) and BPS Analysis by Workflow, 2024 to 2034
Figure 225: Middle East and Africa Market Y-o-Y Growth (%) Projections by Workflow, 2024 to 2034
Figure 226: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 227: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 228: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 229: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034
Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034
Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by End-use, 2019 to 2034
Figure 233: Middle East and Africa Market Value Share (%) and BPS Analysis by End-use, 2024 to 2034
Figure 234: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-use, 2024 to 2034
Figure 235: Middle East and Africa Market Attractiveness by Process, 2024 to 2034
Figure 236: Middle East and Africa Market Attractiveness by Workflow, 2024 to 2034
Figure 237: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 238: Middle East and Africa Market Attractiveness by Application, 2024 to 2034
Figure 239: Middle East and Africa Market Attractiveness by End-use, 2024 to 2034
Figure 240: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the Value of the Induced Pluripotent Stem Cell Market in 2019?
The global induced pluripotent stem cell market was worth US$ 1,427.0 million in 2019.
What is the Sales Outlook for Induced Pluripotent Stem Cells in 2024?
The market for induced pluripotent stem cells is likely to be valued at US$ 2,013.3 million in 2024.
What is the Demand Forecast for Induced Pluripotent Stem Cells by 2034?
The demand for induced pluripotent stem cells is expected to reach a market value of US$ 3,980.8 million by the end of 2034.
What is the Growth Projection for the Induced Pluripotent Stem Cell Market?
The induced pluripotent stem cell market is projected to rise at a CAGR of 7.1% through 2034.
At What Rate is the Market in East Asia Predicted to Grow?
The East Asia market for induced pluripotent stem cells is expected to expand at a CAGR of 9.4% through 2034.
Induced Pluripotent Stem Cell Market